期刊文献+

原发性高血压患者血浆活化血小板表达的研究

Investigation of CD_(62P)(p-selectin)and CD_(63) Expressions in Blood Plasma of Essential Hypertension
下载PDF
导出
摘要 目的:探讨高血压病患者血小板活性因子指标CD62P(P-选择素)、CD63的变化。方法:取158例原发性高血压患者血浆,用流式细胞仪进行检测CD62P(P-选择素)、CD63,自动生化仪测定肾功能、放射免疫法测定血、尿微球蛋白。结果:高血压组CD62P(P-选择素)、CD63均明显高于正常对照组,且随高血压病患者血压分级水平的增高而增高。结论:高血压病患者分级水平的增高与血小板活化指标CD62P(P-选择素)和CD63过度表达有一定的关系,表明其可能参与高血压的发生、发展。 Objective. To investigate the p-selectin and CD63 expression in blood plasma of essential hypertension. Methods.The platelet activity marker(CD62p) p-selectin and CD63 were measured by flow cytometry in 158 hypertensive patients. Bloodα-MG and urineα-MG and renal function were examined. Results:Plasma levels of CD62p (p-selectin) and CD63 in hypertension groups were higher than those of control groups, and There is a positive relationship between the levels of these CD62p(p-selectin) and CD63 and the degree of hypertension. Conclusion. There is a positive relationship between the levels of expression of CD62p (p-selectin)and CD63 and the degrees of hypertension.
出处 《实用临床医学(江西)》 CAS 2007年第2期11-12,15,共3页 Practical Clinical Medicine
基金 2001年江西省卫生厅资助课题
关键词 高血压病 P-选择素 CD63 hypertension p-selectin CD63
  • 相关文献

参考文献13

  • 1Gleerup G,Winther K.Decreased Fibrinolytic Activity and Increased Platelet Function in Hypertension:Possible Influence of Calcium Antagonism[J].Am J Hypertens,1991,4:S168-S171.
  • 2Nityanand S,Pande I,Bajpai V K,et al.Platelets in Essential Hypertension[J].Thromb Res,1993,72:447-454.
  • 3Kjeldsen S E,Gjesdal K,Eide I,et al.Increased β-thromboglobulin in Essential Hypertension:Interactions between Arterial Pasma Arenaline,Ptelet function and Bood Lipids[J].Acta Med Scand,1983,213:369-373.
  • 4Goto S,Tamura N,Eto K,et al.Functional Significance of Adenosine 5'-diphosphate Receptor (P2Y(12) in Platelet Activation Initiated by Binding of Von Willebrand Factor to Platelet GPIb Induced by Conditions of High Shear Rate[J].Circulation,2002,105:2531-2536.
  • 5Spencer C G,Gurney D,Blann A D,et al.Von Willebrand Factor,Soluble P-selectin,and Target Organ Damage in Hypertension:A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)[J].Hypertension,2002,40:61-66.
  • 6Nomura S,Kanazawa S,Fukuhara S.Effects of Efonidipine on Platelet and Monocyte Activation Markers in Hypertensive Ppatients with and Without type 2 Diabetes Mellitus[J].J Hum Hypertens,2002,16:539-547.
  • 7Quan Sang K H,Levenson J,Simon A,et al.Platelet Cytosolic Free Calcium Concentration and Plasma Cholesterol in Untreated Hypertensives[J].J Hypertens,1987,5:S251-S254.
  • 8Lechi C,Sinigaglia D,Delva P,et al.Platelet Intracellular Free Ca2+ after Incubation with Plasma from Hypertensive Patients[J].J Hum Hypertens,1989,3:45-48.
  • 9Yamanishi J,Sano H,Saito K,et al.Plasma Concentrations of Platelet Specific Proteins in Different Stages of Essential Hypertension:Interactions between Platelet Aggregation,Blood Lipids and Age[J].Thromb Haemost,1985,54:539-543.
  • 10Islim I F,Beevers D G,Bareford D.The Effect of Antihypertensive Drugs on in Vivo Platelet Activity in Essential Hypertension[J].J Hypertens,1992,10:379-383.

二级参考文献3

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部